Hookipa PharmaHOOK
13F holders, Q1 2025 (March 31)At the end of Q1 2025, 31 institutions reported holding Hookipa Pharma Inc. (HOOK) in their 13F filings, down 6 from Q4 2024. 4 opened new positions and 10 sold out. The largest holders were Gilead Sciences, Inc. ($2.0M), Baker Bros. Advisors LP ($878K) and Siren, L.L.C. ($612K). 2 famous investors held it, including Jim Simons / Peter Brown (0.0% of Renaissance Technologies's portfolio) and Ken Griffin (0.0% of Citadel Advisors's portfolio).
- Company
- Hookipa Pharma Inc.
- CUSIP
- 43906K209
- Latest filing quarter
- Q3 2025
History
Number of 13F holders
Total Exit/New Position Q4 2024 → Q1 2025
| Institutions | Total Value | |
|---|---|---|
| New Positions | 4 | $39K |
| Exits | 10 | $1.1M |
All 13F filers, Q4 2024 → Q1 2025: 176,073 shares bought and 616,629 shares sold, net −440,556 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 31 holders
| Gilead Sciences, Inc. | 0.17% | No change | 1,875,945 | $2.0M |
| Baker Bros. Advisors LP | 0.01% | No change | 812,814 | $878K |
| Siren, L.L.C. | 0.03% | No change | 566,640 | $612K |
| FMR LLC | 0.00% | Reduce -1.1% | 349,767 | $378K |
| Vanguard Group Inc. | 0.00% | Add +41.1% | 300,819 | $325K |
| Geode Capital Management, LLC | 0.00% | Add +1.1% | 73,432 | $79K |
| Acadian Asset Management LLC | 0.00% | Reduce -8.1% | 55,735 | $59K |
| Ikarian Capital, LLC | 0.02% | No change | 52,996 | $57K |
| Renaissance Technologies | 0.00% | Add +20.6% | 40,970 | $44K |
| Squarepoint Ops LLC | 0.00% | Reduce -21.5% | 40,808 | $44K |
| UBS Group AG | 0.00% | Add +250.5% | 31,054 | $34K |
| Prudential Financial Inc. | 0.00% | Add +152.6% | 28,800 | $31K |
| Dimensional Fund Advisors LP | 0.00% | Reduce -41.5% | 28,431 | $31K |
| Royal Bank of Canada | 0.00% | Add +17.1% | 22,702 | $25K |
| Susquehanna International Group, LLP | 0.00% | New | 19,221 | $21K |
| Morgan Stanley | 0.00% | Reduce -32.0% | 17,247 | $19K |
| State Street Corp. | 0.00% | No change | 16,967 | $18K |
| XTX Topco Ltd | 0.00% | New | 16,186 | $17K |
| Northern Trust Corp. | 0.00% | No change | 15,661 | $17K |
| BlackRock, Inc. | 0.00% | No change | 12,250 | $13K |
| Boothbay Fund Management, LLC | 0.00% | No change | 11,688 | $13K |
| Citadel Advisors | 0.00% | Reduce -68.3% | 10,366 | $11K |
| Tower Research Capital LLC (TRC) | 0.00% | Add +49.5% | 5,150 | $6K |
| JPMorgan Chase & Co. | 0.00% | Add +4.3% | 926 | $1K |
| Osaic Holdings, Inc. | 0.00% | New | 550 | $594 |
| Bank of America Corp. | 0.00% | Add +0.4% | 474 | $512 |
| Wells Fargo & Company | 0.00% | New | 37 | $40 |
| BNP Paribas Financial Markets | 0.00% | No change | 33 | $36 |
| Federation des caisses Desjardins du Quebec | 0.00% | No change | 33 | $36 |
| SBI Securities Co., Ltd. | 0.00% | No change | 13 | $14 |
| Bokf, NA | 0.00% | No change | 8 | $9 |
"% of holder's portfolio" is HOOK's weight in each manager's 13F, not the share of Hookipa Pharma Inc. the manager owns.